|
2025
|
Invention
|
Compounds as ccr6 inhibitors.
The present invention provides new derivatives having the general ... |
|
|
Invention
|
Combinations and uses thereof.
The present invention provides novel combination therapies compri... |
|
|
Invention
|
Enzyme and pathway modulation with sulfhydryl compounds and their derivatives.
The present inven... |
|
|
Invention
|
Payload-bearing multispecific antibodies.
The present disclosure relates to a variant of ForCE t... |
|
|
Invention
|
Novel pyrimidinyl sulfonamide derivatives.
The invention relates to novel compounds having the g... |
|
|
Invention
|
Generative protein design with composable energy-based models.
A method may include identifying ... |
|
|
Invention
|
Automated assessment of endoscopic disease.
The application relates to devices and methods for a... |
|
|
Invention
|
Ph-gradient spr-based binding assay.
Herein is reported a method for determining the dissociatio... |
|
|
Invention
|
Iterative training with pseudo-matched molecule pairs for machine learning enabled enhancement of... |
|
|
Invention
|
Implicitly guided generation by matching data points.
An input molecule exhibiting a value for o... |
|
|
Invention
|
Machine learning enabled enhancement of molecular properties. An input molecule exhibiting a valu... |
|
|
Invention
|
Machine learning enabled enhancement of molecular properties.
An input molecule exhibiting a val... |
|
|
Invention
|
Structure-informed machine learning enabled enhancement of molecular properties.
An input molecu... |
|
|
Invention
|
Method for generating spinal cord synthetic mri data. The present invention concern the field of ... |
|
|
Invention
|
Methods for treatment of inflammatory bowel disease with an anti-tl1a antibody. The present discl... |
|
|
Invention
|
Quinazolinone compound as braf inhibitor for the treatment of advanced solid cancer or metastases... |
|
|
Invention
|
Three-dimensional molecule generation. A method for generating an output molecule may include det... |
|
|
Invention
|
Recombinant binding proteins with conditionally activatable t cell and nk cell recruiting effecto... |
|
|
Invention
|
Antigen binding molecules. The present invention relates to a pair of binding molecules comprisin... |
|
|
Invention
|
Device for determining a fill level of a liquid in a container, apparatus, system and method. The... |
|
|
Invention
|
Recombinant fc domain – il7 variant polypeptides and combination therapy with membrane-anchored a... |
|
|
Invention
|
Pharmacodynamics modelling. in vivo in vitroin vivoin vivo level profile for each of said one or ... |
|
|
Invention
|
Use of atr inhibitors in combination with anti-pd(l)1 therapy. Disclosed are methods of treating ... |
|
|
Invention
|
Use of atr inhibitors in combination with antiandrogen agent. Disclosed are methods of treating a... |
|
|
Invention
|
Dose regimen for a 7-phenoxy-n-(3-azabicyclo[3.2.1]octan-8-yl)-6,7-dihydro-5h-pyrrolo[1,2-b][1,2,... |
|
|
Invention
|
Treatment and prevention of muscular dystrophy and its related diseases or disorders with satrali... |
|
|
Invention
|
Novel process for the synthesis of substituted morpholines and thiomorpholines. The present inven... |
|
|
Invention
|
Methods and systems for determining an actual ph in a liquid phase of a tank. 2222222222 concentr... |
|
|
Invention
|
Kred catalyzed ketoreduction of a cyclobutanone carbamic ester. Disclosed, inter alia, are proces... |
|
|
Invention
|
Anti-drug antibody assays. The present invention is in the field of immunoassays, particularly in... |
|
|
Invention
|
Chiral aminophosphine ligands, iridium catalysts comprising these ligands and use of these cataly... |
|
|
Invention
|
Predicting response to il-6 antagonists.
The invention is concerned with a method of predicting ... |
|
|
Invention
|
Combination treatment of glofitamab and chemotherapy.
The present invention relates to methods o... |
|
|
Invention
|
New interleukin-7 immunoconjugates.
The present invention generally relates to mutant interleuki... |
|
|
Invention
|
Combination therapy with targeted 4-1bb (cd137) agonists.
The present invention relates to combi... |
|
|
Invention
|
T cell receptor identification.
The present disclosure relates to the fields of molecular biolog... |
|
|
Invention
|
Identification of patients in need of pd-l1 inhibitor cotherapy.
The present invention relates t... |
|
|
Invention
|
Method for generating multispecific antibodies from monospecific antibodies.
Herein is reported ... |
|
|
Invention
|
Pertuzumab plus trastuzumab fixed dose combination.
The invention disclosed concerns a fixed dos... |
|
2024
|
Invention
|
Cd123 and cd200 as markers for the diagnosis and immune-eradication of leukemic stem cells (lscs)... |
|
|
Invention
|
Antisense oligonucleotides for targeting progranulin.
Antisense oligonucleotides for altering th... |
|
|
Invention
|
Ricyclic heteroaryl derivatives.
The invention provides new bicyclic heteroaryl compounds having... |
|
|
Invention
|
Interferon gamma variants and antigen binding molecules comprising these.
The invention relates ... |
|
|
Invention
|
Antisense oligonucleotide for targeting progranulin.
The present invention relates to oligonucle... |
|
|
P/S
|
Antibiotic Preparation |
|
2023
|
Invention
|
Oct retinal volumetric measurements based on etdrs grid.
A method for performing retinal volumet... |
|
|
Invention
|
Novel compounds.
The invention relates to novel compounds having the general formula (Ib) or (Ib... |
|
|
Invention
|
Methods and systems for predicting cancer therapy response.
The present invention provides a com... |
|
|
Invention
|
Identification of features for predicting a particular characteristic.
A computer-implemented me... |
|
|
Invention
|
Drug production method.
A method for producing at least one drug product using a lyophilization ... |
|
2022
|
P/S
|
Online-information services, namely, providing on-line information about accessing computer netwo... |
|
2019
|
P/S
|
Medical and scientific research in the field of diabetes; Consultation pertaining to pharmacology... |
|
2017
|
P/S
|
laboratory instruments, namely, clinical chemistry analyzers and immunochemistry analyzers for th... |
|
|
P/S
|
a full line of in vitro diagnostic agent, namely, reagents, control solutions for calibrating and... |
|
|
P/S
|
medical diagnostic test strips for determining the level of glucose in blood for medical and clin... |
|
|
P/S
|
blood glucose monitors for medical purposes, lancet devices, lancets; insulin delivery devices an... |
|
2008
|
P/S
|
full line of pharmaceutical preparations |
|
|
P/S
|
pharmaceutical antiviral preparation |
|
2000
|
P/S
|
[ Chemical products, namely, diagnostic preparations for scientific or medical research use; cont... |
|
1999
|
P/S
|
providing information about a pharmaceutical company and its products and services via a web site... |
|
1997
|
P/S
|
pharmaceutical preparation, namely, an anticancer drug |
|
1994
|
P/S
|
pharmaceutical preparation; namely, an antiviral |
|
1993
|
P/S
|
pharmaceutical preparation, namely an immunosuppressive agent |
|
1985
|
P/S
|
COMPUTERS AND ELECTRONIC LABORATORY TESTING APPARATUS USED FOR ANALYSIS OF BIOLOGICAL FLUIDS, PHA... |
|
1984
|
P/S
|
Clinical Laboratory Services |
|
1977
|
P/S
|
[ PROVIDING COMPUTER SCORED PSYCHIATRIC AND PSYCHOLOGICAL TESTING SERVICES; ] PROVIDING PHARMACEU... |
|
|
P/S
|
MEDICAL BOOKLETS AND PAMPHLETS |
|
|
P/S
|
PHARMACEUTICAL PREPARATIONS FOR HUMAN [AND VETERINARY] USE |
|
|
P/S
|
IN VITRO DIAGNOSTIC REAGENTS[; ULTRASONIC COUPLING MEDIUM; AND CHEMICAL PREPARATION USED IN THE C... |
|
|
P/S
|
IN VITRO DIAGNOSTIC REAGENTS [ ; ULTRASONIC COUPLING MEDIUM; AND CHEMICAL PREPARATION USED IN THE... |
|
1949
|
P/S
|
[ AGENTS USED IN ALLERGY, ANALGESICS, ANALEPTICS, ] ANTI-INFECTIVES [, ANTISPASMODICS ANESTHETIC... |
|
1897
|
P/S
|
CHEMICAL PRODUCTS FOR USE IN MEDICINE AND PHARMACY [ , DISINFECTANTS, AND PERFUMES ] |
